Clinical Trial Update: A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating LY4005130 in adults with severe alopecia areata is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• LY4005130 (LY4005130)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Alopecia Areata | Phase 2 | Status: NOT_YET_RECRUITING